171 related articles for article (PubMed ID: 37147713)
1. SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.
Li Z; Tao Y; Gao Z; Peng S; Lai Y; Li K; Chen X; Huang H
J Transl Med; 2023 May; 21(1):303. PubMed ID: 37147713
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
Li Y; Gao Y; Xu Y; Ma H; Yang M
Growth Factors; 2015; 33(4):267-74. PubMed ID: 26359764
[TBL] [Abstract][Full Text] [Related]
3. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
[TBL] [Abstract][Full Text] [Related]
4. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
Xu W; Chang J; Du X; Hou J
Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
8. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CDKN2B-AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis.
Zhu JL; Xue WB; Jiang ZB; Feng W; Liu YC; Nie XY; Jin LY
Kaohsiung J Med Sci; 2022 Dec; 38(12):1144-1154. PubMed ID: 36161699
[TBL] [Abstract][Full Text] [Related]
10. miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.
Xiao P; Liu W; Zhou H
Mol Med Rep; 2016 Aug; 14(2):1835-40. PubMed ID: 27356635
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting FSCN1.
Yu S; Xie H; Zhang J; Wang D; Song Y; Zhang S; Zheng S; Wang J
Mol Med Rep; 2017 Dec; 16(6):9707-9714. PubMed ID: 29039557
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
Zhang Y; Yang X; Wu H; Zhou W; Liu Z
Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
[TBL] [Abstract][Full Text] [Related]
13. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
Chang D; Liu XX; Liu R; Sun JW
Yi Chuan; 2023 Feb; 45(2):115-127. PubMed ID: 36927659
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
15. The post-translational modification of Fascin: impact on cell biology and its associations with inhibiting tumor metastasis.
Nan-Li ; Zhang ZD; Li RR; Chen JY; Huang HX; Cheng YW; Xu LY; Li EM
Amino Acids; 2022 Dec; 54(12):1541-1552. PubMed ID: 35939077
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
Lai C; Chen Z; Li R
Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
[TBL] [Abstract][Full Text] [Related]
17. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
[TBL] [Abstract][Full Text] [Related]
18. m
Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis.
Wang Q; Wang LX; Zhang CY; Bai N; Feng C; Zhang ZM; Wang L; Gao ZZ
Mol Cell Biochem; 2022 May; 477(5):1477-1488. PubMed ID: 35166986
[TBL] [Abstract][Full Text] [Related]
20. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]